Bank Of New York Mellon Corp Eq Rx, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.8 - $2.83 $1.54 Million - $2.42 Million	854,848 New	854,848 $1.66 Billion
Q4 2022 Feb 14, 2023	BUY	$2.05 - $5.5 $1.77 Million - $4.74 Million	861,334 New	861,334 $2.12 Million
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $259,683 - $1.65 Million	276,259 Added 47.46%	858,315 $4.25 Million
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $1.54 Million - $2.74 Million	481,663 Added 479.78%	582,056 $2.73 Million
Q1 2022 May 11, 2022	BUY	$2.8 - $7.39 $281,100 - $741,904	100,393 New	100,393 $415,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.